Observational studyBMC infectious diseases2026
Pulmonary artery pseudoaneurysm as a neglected manifestation of pulmonary mucormycosis: a retrospective observational study.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pulmonary mucormycosis: Imaging findings and implications.Lung India : official organ of Indian Chest Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPulmonary artery pseudoaneurysm (PAP) is a rare but potentially fatal vascular abnormality, while its occurrence secondary to pulmonary mucormycosis (PM) is uncommon. The coexistence of PAP and PM represents an exceedingly uncommon and life-threatening condition, with only a limited number of cases reported in the literature.
methodWe retrospectively analyzed medical records of 69 patients diagnosed with PM at the Center of Rare Lung Diseases and Respiratory Infections, National Lung Hospital, Hanoi, Vietnam, between January 2020 and April 2025. Among them, nine patients with concomitant PAP were identified, and detailed data on clinical characteristics, diagnostic evaluations, management, and outcomes were extracted from electronic medical records.
resultsThe nine patients had a median age of 61 years (range 51-88), with males predominating and diabetes mellitus documented in eight cases, most of which were poorly controlled. Hemoptysis was mild in the majority, with only one patient developing massive bleeding. Chest CT revealed 16 PAPs (10 round type, 5-40 mm in diameter), with bilateral involvement in over half of the patients. Surrounding abnormalities of PAPs included pulmonary consolidation in all nine cases and necrosis in eight. Management included surgical resection in five patients, and antifungal therapy with amphotericin B followed by triazoles, but three patients died, two from fatal hemoptysis.
conclusionSystematic screening for PAP in PM, especially in patients with poorly controlled diabetes and pulmonary consolidation or necrosis, along with early antifungal therapy and timely surgical intervention, may improve survival in this rare but life-threatening condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.